Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole
NCT02986685 · Xijing Hospital of Digestive Diseases · PHASE4 · withdrawn · last registry update 2023-02-01 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Lack of funds” | – | Registry record, Xijing Hospital of Digestive Diseases |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ATP4A within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-01-30Results posted on the registry: Providence Health & Services, Cyclophosphamide + Indomethacin (NCT02950259)
- 2023-12-08Phase 3 first posted: Alexandria University, Vonoprazan + Amoxicillin (NCT06162949)
- 2023-11-01Results posted on the registry: Cinclus Pharma Holding AB, X842 + X842 Dummy (NCT05055128)
- 2023-05-12Phase 3 first posted: TenNor Therapeutics (Suzhou) Limited, Rifasutenizol capsules + Rabeprazole sodium enteric-coated tablets (NCT05857163)
- 2023-03-03Phase 3 first posted: Biao Zou, FMT + Conventional drugs (NCT05753774)
- 2023-01-11Phase 3 first posted: Aya Mohamed Sadek Elsaid, Omeprazole (NCT05680870)
- 2022-12-12Phase 3 first posted: Hoffmann-La Roche, Inavolisib + Fulvestrant (NCT05646862)
- 2022-07-07Phase 3 first posted: Onconic Therapeutics Inc., JP-1366 20mg + Lansoprazole 30mg (NCT05448001)
- 2022-07-05Phase 3 first posted: Onconic Therapeutics Inc., JP-1366 20mg + Esomeprazole 40mg (NCT05443984)
- 2022-03-04Phase 3 first posted: AstraZeneca, Nexium 20mg + Nexium 10mg (NCT05267613)
- 2022-02-07Phase 3 first posted: Alexandria University, Vonoprazan fumarate (Vonaspire) + Pantoprazole 40mg (NCT05227833)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision